Neuralstem, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 82   

Articles published

CUR 3.82 -0.20 (-4.98%)
price chart
Can Shares Of Neuralstem, Inc. (NASDAQ: CUR) Hit $4?
Neuralstem, Inc. (NASDAQ: CUR) is facing the threat of losing its NASDAQ listing on two accounts. The stock's market price of about $0.30 is well below the minimum price requirement of $1 for continued listing on NASDAQ.
Two Biotechnology Names Are Hot: Sarepta Therapeutics, Inc. (SRPT), Neuralstem ...
Sarepta Therapeutics, Inc. (SRPT) ended last trading session with a change of 1.9 percent. It trades at an average volume of 2.47M shares versus 3.24M shares recorded at the end of last trading session.
Neuralstem Announces Presentations at Upcoming Scientific Conferences
GERMANTOWN, Md., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, announced poster ...
Neuralstem, Inc. (NASDAQ:CUR) Analyst Estimates
Neuralstem, Inc. (NASDAQ:CUR) stock is presently standing at about $0.31 and lots of equity research firms seem to have a target price set on the stock.
Reviewing Hot Stock of Yesterday- Neuralstem, Inc. (NASDAQ:CUR)  Hot Stocks Point
Neuralstem completes round trip
Thinly traded nano cap Neuralstem (CUR -1.8%) provides the latest example of the dangers of chasing "big pops" in biotech.
Hot Biotech Stocks To Watch Right Now: Neuralstem, Inc. (CUR), Amgen Inc. (AMGN)
Neuralstem, Inc. (CUR) ended last trading session with a change of 16.67 percent. It trades at an average volume of 499.08K shares versus 3.05M shares recorded at the end of last trading session.
Brean Capital Reiterated Buy on Neuralstem, Inc. (CUR) Following Preclinical ...
In a research report issued Thursday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Neuralstem, Inc. (NASDAQ:CUR), with an $8.00 price target, after the biotech company announced additional in vitro data on NSI-189, ...
Stock Update (NASDAQ:CUR): Neuralstem, Inc. Presents NSI-189 Preclinical ...
CUR Neuralstem, Inc. (NASDAQ:CUR) announced the presentation of the poster entitled, “Reversal of radiation-induced cognitive impairment by oral administration of a neurogenic small molecule compound NSI-189,” at the Radiation Research Society ...
Neuralstem Inc. (CUR) Jumps 40% on August 16
Neuralstem Inc. (CUR) was among the biggest gainers on the Russell 2000 for Tuesday August 16 as the stock popped 40% to $0.29, representing a gain of $0.084 per share.
Heavy Volume Healthcare Stocks: Synergy Pharmaceuticals Inc. (NASDAQ:SGYP ...
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) shares ended at $6.73 with 3.95 mln shares exchanging hands. That puts the market capitalization at $1.18 bln.